{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:23:07Z","timestamp":1787750587666,"version":"build-2784847793"},"reference-count":10,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,26]]},"DOI":"10.1515\/jtim-2026-0074","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:00:08Z","timestamp":1787749208000},"page":"514-516","source":"Crossref","is-referenced-by-count":0,"title":["Dual targeting of ferroptosis and immune evasion: STAT3 inhibition as a one-two punch for breast cancer immunotherapy"],"prefix":"10.1515","volume":"14","author":[{"given":"Jianbo","family":"Zhou","sequence":"first","affiliation":[{"name":"West China School of Pharmacy, Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University , Chengdu , Sichuan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailu","family":"Song","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, University of South Florida , Tampa , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-782X","authenticated-orcid":false,"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0289-4426","authenticated-orcid":false,"given":"Fu","family":"Peng","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University , Chengdu , Sichuan Province , China"},{"name":"West China School of Pharmacy, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, Sichuan University , Chengdu , Sichuan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2026082612595946345_j_jtim-2026-0074_ref_001","doi-asserted-by":"crossref","unstructured":"Yamaguchi H, Hsu JM, Yang WH, Hung MC. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat Rev Clin Oncol 2022;19:287\u2013305.","DOI":"10.1038\/s41571-022-00601-9"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_002","doi-asserted-by":"crossref","unstructured":"Dai Y, Cui C, Jiao D, Zhu X. JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases. Cancer Cell Int 2025;25:83.","DOI":"10.1186\/s12935-025-03681-6"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_003","doi-asserted-by":"crossref","unstructured":"Zhou J, Yang W, Tang H, Zou Y, Zhou Z, Peng C, et al. Co-targeting ferroptosis and immune evasion through small molecules in breast cancer. J Transl Int Med 2025;13:516\u2013536.","DOI":"10.1515\/jtim-2025-0093"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_004","doi-asserted-by":"crossref","unstructured":"Zhou J, Zhang H, Pan WW, Peng C, Tang H, Yuan G, et al. Isocucurbitacin B targets STAT3 to induce ferroptosis and promote anti-PD1 immunotherapy responses in breast cancer. Int J Surg 2026;112:11404\u201311424.","DOI":"10.1097\/JS9.0000000000004907"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_005","doi-asserted-by":"crossref","unstructured":"An J, Zhang L, Duan Y, Pu S, Peng F. Sodium's role and therapeutic targeting in cancer. Trends Pharmacol Sci 2026;47:53\u201365.","DOI":"10.1016\/j.tips.2025.10.015"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_006","doi-asserted-by":"crossref","unstructured":"Jiang S, Liu K, Jiang T, Li H, Wei X, Wan X, et al. Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha. Nat Commun 2025;16:7854.","DOI":"10.1038\/s41467-025-62288-7"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_007","doi-asserted-by":"crossref","unstructured":"Lin Z, Liu J, Long F, Kang R, Kroemer G, Tang D, et al. The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat Commun 2022;13:7965.","DOI":"10.1038\/s41467-022-35707-2"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_008","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang Z, Li S, Ma J, Dai X, Lu J. Deciphering JAK\/STAT signaling pathway: a multifaceted approach to tumorigenesis, progression and therapeutic interventions. Int Immunopharmacol 2024;131:111846.","DOI":"10.1016\/j.intimp.2024.111846"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_009","doi-asserted-by":"crossref","unstructured":"Chen M, Wang S. Preclinical development and clinical studies of targeted JAK\/STAT combined Anti-PD-1\/PD-L1 therapy. Int Immunopharmacol 2024;130:111717.","DOI":"10.1016\/j.intimp.2024.111717"},{"key":"2026082612595946345_j_jtim-2026-0074_ref_010","doi-asserted-by":"crossref","unstructured":"Kang Z, Li S, Li Y, Song J, Peng Y, Chen Y. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: an updated review (from 2022 to 2024). Chin Chem Lett 2025;36:110447.","DOI":"10.1016\/j.cclet.2024.110447"}],"container-title":["Journal of Translational Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0074\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0074\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:02:11Z","timestamp":1787749331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0074\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,26]]},"published-print":{"date-parts":[[2026,8,26]]}},"alternative-id":["10.1515\/jtim-2026-0074"],"URL":"https:\/\/doi.org\/10.1515\/jtim-2026-0074","relation":{},"ISSN":["2224-4018"],"issn-type":[{"value":"2224-4018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}